<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">66097</article-id><article-id pub-id-type="doi">10.7554/eLife.66097</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Neuroscience</subject></subj-group><subj-group subj-group-type="heading"><subject>Structural Biology and Molecular Biophysics</subject></subj-group></article-categories><title-group><article-title>Architecture and structural dynamics of the heteromeric GluK2/K5 kainate receptor</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-220547"><name><surname>Khanra</surname><given-names>Nandish</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-4217-1273</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-146205"><name><surname>Brown</surname><given-names>Patricia MGE</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-8340-0330</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-146203"><name><surname>Perozzo</surname><given-names>Amanda M</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-9681-3548</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-66115"><name><surname>Bowie</surname><given-names>Derek</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-9491-8768</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-3"/><xref ref-type="other" rid="par-4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-104022"><name><surname>Meyerson</surname><given-names>Joel</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-6127-0093</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Physiology and Biophysics</institution>, <institution>Weill Cornell Medical College</institution>, <addr-line><named-content content-type="city">New York</named-content></addr-line>, <country>United States</country></aff><aff id="aff2"><institution content-type="dept">Pharmacology &amp; Therapeutics</institution>, <institution>McGill University</institution>, <addr-line><named-content content-type="city">Montreal</named-content></addr-line>, <country>Canada</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-23006"><name><surname>Maduke</surname><given-names>Merritt</given-names></name><role>Reviewing editor</role><aff><institution>Stanford University School of Medicine</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>jrm2008@med.cornell.edu</email> (JM);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>16</day><month>03</month><year>2021</year></pub-date><volume>10</volume><elocation-id>e66097</elocation-id><history><date date-type="received"><day>29</day><month>12</month><year>2020</year></date><date date-type="accepted"><day>05</day><month>03</month><year>2021</year></date></history><permissions><copyright-statement>© 2021, Khanra et al</copyright-statement><copyright-year>2021</copyright-year><copyright-holder>Khanra et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-66097-v1.pdf"/><abstract><p>Kainate receptors (KARs) are L-glutamate-gated ion channels that regulate synaptic transmission and modulate neuronal circuits. KARs have strict assembly rules and primarily function as heteromeric receptors in the brain. A longstanding question is how KAR heteromer subunits organize and coordinate together to fulfill their signature physiological roles. Here we report structures of the GluK2/GluK5 heteromer in apo, antagonist-bound, and desensitized states. The receptor assembles with two copies of each subunit, ligand binding domains arranged as two heterodimers, and GluK5 subunits proximal to the channel. Strikingly, during desensitization GluK2 but not GluK5 subunits undergo major structural rearrangements to facilitate channel closure. We show how the large conformational differences between antagonist-bound and desensitized states are mediated by the linkers connecting the pore helices to the ligand-binding domains. This work presents the first KAR heteromer structure, reveals how its subunits are organized, and resolves how the heteromer can accommodate functionally-distinct closed channel structures.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100007027</institution-id><institution>Leon Levy Foundation</institution></institution-wrap></funding-source><award-id>N/A</award-id><principal-award-recipient><name><surname>Meyerson</surname><given-names>Joel</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000156</institution-id><institution>Fonds de Recherche du Québec - Santé</institution></institution-wrap></funding-source><award-id>N/A</award-id><principal-award-recipient><name><surname>Brown</surname><given-names>Patricia MGE</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000024</institution-id><institution>Canadian Institutes of Health Research</institution></institution-wrap></funding-source><award-id>136832</award-id><principal-award-recipient><name><surname>Bowie</surname><given-names>Derek</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000024</institution-id><institution>Canadian Institutes of Health Research</institution></institution-wrap></funding-source><award-id>162317</award-id><principal-award-recipient><name><surname>Bowie</surname><given-names>Derek</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>Cryo-EM density maps have been deposited in the Electron Microscopy Data Bank (EMDB) under accession numbers EMD-23017 (GluK2/K5-apo), EMD-23014 (GluK2/K5-CNQX), and EMD-23015 (GluK2/K5-L-Glu). Model coordinates have been deposited in the Protein Data Bank (PDB) under accession numbers 7KS0 (GluK2/K5-CNQX) and 7KS3 (GluK2/K5-L-Glu). Raw cryo-EM data will be publicly available on the EMPIAR repository upon publication under the accession numbers: EMPIAR-10658, EMPIAR-10659, EMPIAR-10660</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Khanra N</collab><collab>Brown PMGE</collab><collab>Perozzo AM</collab><collab>Bowie D</collab><collab>Meyerson JR</collab></person-group><year iso-8601-date="2021">2021</year><source>Glu2/K5 apo</source><ext-link ext-link-type="uri" xlink:href="https://www.ebi.ac.uk/pdbe/emdb/empiar/entry/10658/">https://www.ebi.ac.uk/pdbe/emdb/empiar/entry/10658/</ext-link><comment>EMPIAR, EMPIAR-10658</comment></element-citation><element-citation id="dataset2" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Khanra N</collab><collab>Brown PMGE</collab><collab>Perozzo AM</collab><collab>Bowie D</collab><collab>Meyerson JR</collab></person-group><year iso-8601-date="2021">2021</year><source>GluK2/K5 with 6-Cyano-7-nitroquinoxaline-2,3-dione (CNQX)</source><ext-link ext-link-type="uri" xlink:href="https://www.ebi.ac.uk/pdbe/emdb/empiar/entry/10659/">https://www.ebi.ac.uk/pdbe/emdb/empiar/entry/10659/</ext-link><comment>EMPIAR, EMPIAR-10659</comment></element-citation><element-citation id="dataset3" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Khanra N</collab><collab>Brown PMGE</collab><collab>Perozzo AM</collab><collab>Bowie D</collab><collab>Meyerson JR</collab></person-group><year iso-8601-date="2021">2021</year><source>GluK2/K5 with L-Glu</source><ext-link ext-link-type="uri" xlink:href="https://www.ebi.ac.uk/pdbe/emdb/empiar/entry/10660/">https://www.ebi.ac.uk/pdbe/emdb/empiar/entry/10660/</ext-link><comment>EMPIAR, EMPIAR-10660</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-66097-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>